Following a screening of the NOVA documentary, “Secrets in our DNA,” the Computer History Museum hosted a panel with science and business experts about personal genetic testing. Click the link below to hear contributions by G2P director Dr. Green.
In this NOVA documentary, G2P director Dr. Green explains what DNA can reveal about our ancestry and health, and at what risk.
In the first of a two-part series, AMA Chief Experience Officer Todd Unger discusses genetics at play in COVID-19 with experts Wendy Chung, MD, PhD, Robert Green, MD, MPH, and AMA’s Chief Health and Science Officer Mira Irons, MD.
Boston researchers using COVID-19 patients’ DNA to unlock secrets about impact of virus
Dr. Robert Green is the director of the Preventive Genomics Clinic at Brigham and Women’s Hospital in Boston. He believes that DNA testing combined with proper counseling and medical follow-up would be a critical element of a healthcare system that can prevent illness.
At a new clinic in Boston, genetic counselor Carrie Blout helps healthy patients get their DNA tested for predispositions to more than 2500 diseases. Bloomberg’s Aki Ito goes through the testing herself, trialing a controversial technology at the forefront of modern medicine.
Dr. Robert Green shares the findings from the BabySeq project to showcase the need for preventive genomics in clinical care.
Researchers analyzed nearly 5,000 genes looking for the risk of diseases and found that almost 10 percent of babies tested were at risk for a condition that could be treated early.
Dr. Robert C. Green speaks at the 2018 Advances in Genome Biology and Technology (AGBT) Precision Health Conference in San Diego, California about our efforts to gather empirical data on genome sequencing healthy individuals. Watch to learn more about G2P’s MilSeq, BabySeq, MedSeq, PeopleSeq, PGen and REVEAL projects. Click here for more on the conference.
Our very own Dr. Robert Green along with other genomic experts discuss “Deep Dive: Genetics and Genomics, Today and Tomorrow” explaining how genomics is changing much of what we know about medicine and what we can expect in the future at the Aspen Ideas Festival 2018. Additionally, Dr. Green presents “Med School: Separating Hype from Hope … Continued
Follow new parents Katherine and Jason as they meet with Genomes2People Genetic Counselors to learn about their baby boy’s genome sequencing results as part of our BabySeq Project.
Dr. Robert C. Green talks about The BabySeq Project, the world’s first study of genetically sequencing newborns, and how genetic information can influence one’s medical care beginning from birth.
Genomic testing for Baby Cora, a participant of The BabySeq Project, revealed a disorder that might otherwise have gone undetected until life-long health issues presented themselves.
Gaining information by getting your DNA sequenced on what diseases you have risks for and can take preventative measures based on this information
Megan Tirrell seeks out Dr. Robert Green to have her genome sequenced and discusses her experience through the entire process; from meetings with the genetic counselors and learning about cost and variants of unknown significance, to getting her results in her disclosure meetings.
“For the first time ever doctors at Brigham & Women’s and Boston Children’s Hospital are sequencing the genome of newborns. This allows doctors to decode the DNA and look for the possibility of future diseases and conditions.”
When one family member of the Guisti family decided to get genetic testing, it set a domino effect for the entire family because of what was revealed within her genome.
Dr. Robert Green discusses how direct-to-consumer testing is used to find specific markers in your DNA that might code for specific diseases, whether accurate of not. He mentions that a whole genome sequencing, rather than a test that only codes for specific markers, is probably more accurate.
Eli Karlin took a DNA test he ordered online to reveal a history of breast cancer within his family that they had not known about.